Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
T.W. Evans.
Review article: albumin as a drug-biological effects of albumin unrelated to oncotic pressure.
Aliment Pharmacol Ther, 16 (2002), pp. 6-11
[2.]
C.M. Redman.
Biosynthesis of serum proteins and ferritin by free and attached ribosomes of rat liver.
Biochem Biophys Res Commun, 33 (1968), pp. 55-60
[3.]
S.R. Kimball, R.L. Horetsky, L.S. Jefferson.
Hormonal regulation of albumin gene expression in primary cultures of rat hepatocytes.
Am J Physiol, 268 (1995), pp. E6-E14
[4.]
G.J. Quinlan, M.P. Margarson, S. Mumby, T.W. Evans, J.M. Gutteridge.
Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion.
Clin Sci (Lond), 95 (1998), pp. 459-465
[5.]
P. Rhee, D. Wang, P. Ruff, B. Austin, S. DeBraux, K. Wolcott, et al.
Human neutrophil activation and increased adhesion by various resuscitation fluids.
Crit Care Med, 28 (2000), pp. 74-78
[6.]
C. Nathan, Q.W. Xie, L. Halbwachs-Mecarelli, W.W. Jin.
Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin).
J Cell Biol, 122 (1993), pp. 243-256
[7.]
P. Sorkine, R. Ben Abraham, O. Szold, P. Biderman, A. Kidron, H. Merchav, et al.
Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure.
Crit Care Med, 29 (2001), pp. 1332-1336
[8.]
M. Maciá, J. Avilés, J. Navarro, S. Morales, J. García.
Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis.
Am J Med, 114 (2003), pp. 62-64
[9.]
R.W. Schrier, V. Arroyo, M. Bernardi, M. Epstein, J.H. Henriksen, J. Rodes.
Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
Hepatology, 8 (1988), pp. 1151-1157
[10.]
W.H. Abelmann.
Hyperdynamic circulation in cirrhosis: a historical perspective.
Hepatology, 20 (1994), pp. 1356-1358
[11.]
R.W. Schrier, M. Niederberger, A. Weigert, P. Gines.
Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis.
Semin Liver Dis, 14 (1994), pp. 14-22
[12.]
P.Y. Martín, P. Ginès, R.W. Schrier.
Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.
N Engl J Med, 339 (1998), pp. 533-541
[13.]
P. Ginès, M. Guevara, V. Arroyo, J. Rodes.
Hepatorrenal syndrome.
Lancet, 362 (2003), pp. 1819-1827
[14.]
P. Ginès, V. Arroyo, J. Rodés.
Disorders of renal function in cirrhosis: pathophysiology and clinical aspects.
Hepatology: a textbook of liver disease, 3th ed.,
[15.]
L. Ruiz-del-Árbol, J. Urman, J. Fernández, M. González, M. Navasa, A. Monescillo, et al.
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.
Hepatology, 38 (2003), pp. 1210-1218
[16.]
M.D. Shapiro, K.M. Nicholls, B.M. Groves, R. Kluge, H.M. Chung, D.G. Bichet, et al.
Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients.
Kidney Int, 28 (1985), pp. 206-211
[17.]
K.M. Nicholls, M.D. Shapiro, B.S. Groves, R.W. Schrier.
Factors determining renal response to water immersion in non-excretor cirrhotic patients.
Kidney Int, 30 (1986), pp. 417-421
[18.]
K. Lenz, W. Druml, G. Kleinberger, H. Hortnagl, A. Laggner, B. Schneeweiss, et al.
Enhancement of renal function with ornipressin in a patient with decompensated cirrhosis.
Gut, 26 (1985), pp. 1385-1386
[19.]
K. Lenz, H. Hortnagl, W. Druml, G. Grimm, A. Laggner, B. Schneeweisz, et al.
Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis.
Gut, 30 (1989), pp. 90-96
[20.]
K. Lenz, H. Hortnagl, W. Druml, H. Reither, R. Schmid, B. Schneeweiss, et al.
Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor.
Gastroenterology, 101 (1991), pp. 1060-1067
[21.]
M. Guevara, P. Ginès, G. Fernández-Esparrach, P. Sort, J.M. Salmerón, W. Jiménez, et al.
Reversibility of hepatorrenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
Hepatology, 27 (1998), pp. 35-41
[22.]
R. Ortega, P. Ginés, J. Uriz, A. Cardenas, B. Calahorra, D. De Las Heras, et al.
Terlipressin therapy with and without albumin for patients with hepatorrenal syndrome: results of a prospective, nonrandomized study.
Hepatology, 36 (2002), pp. 941-948
[23.]
P. Ginés, V. Arroyo, E. Quintero, R. Planas, F. Bory, J. Cabrera, et al.
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
Gastroenterology, 93 (1987), pp. 234-241
[24.]
F. Salerno, S. Badalamenti, P. Incerti, S. Tempini, B. Restelli, S. Bruno, et al.
Repeated paracentesis and i.v. albumin infusion to treat tense ascites in cirrhotic patients. A safe alternative therapy.
J Hepatol, 5 (1987), pp. 102-108
[25.]
S.K. Acharya, S. Balwinder, A.K. Padhee, S. Nijhawan, B.N. Tandon.
Large volume paracentesis and intravenous dextran to treat tense ascites.
J Clin Gastroenterol, 14 (1992), pp. 31-35
[26.]
P. Ginès, L. Tito, V. Arroyo, R. Planas, J. Panes, J. Viver, et al.
Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
Gastroenterology, 94 (1988), pp. 1493-1502
[27.]
M. Pozzi, G. Osculati, G. Boari, P. Serboli, P. Colombo, C. Lambrughi, et al.
Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.
Gastroenterology, 106 (1994), pp. 709-719
[28.]
A. Luca, J.C. García-Pagán, J. Bosch, F. Feu, W. Jiménez, A. Ginés, et al.
Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.
Hepatology, 22 (1995), pp. 753-758
[29.]
J. Salo, A. Ginés, P. Ginès, C. Piera, W. Jiménez, M. Guevara, et al.
Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis.
J Hepatol, 27 (1997), pp. 645-653
[30.]
L. Ruiz-del-Árbol, A. Monescillo, W. Jiménez, A. García-Plaza, V. Arroyo, J. Rodes.
Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.
Gastroenterology, 113 (1997), pp. 579-586
[31.]
A. Ginés, G. Fernández-Esparrach, A. Monescillo, C. Vila, E. Domenech, R. Abecasis, et al.
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated byparacentesis.
Gastroenterology, 111 (1996), pp. 1002-1010
[32.]
J. Sola-Vera, J. Minana, E. Ricart, M. Planella, B. González, X. Torras, et al.
Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
Hepatology, 37 (2003), pp. 1147-1153
[33.]
V. Arroyo, J. Colmenero.
Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict.
Dig Liver Dis, 35 (2003), pp. 668-672
[34.]
M. Guevara, C. Alessandria, R. Ortega, R. Durández, D. De las Heras, J. Uriz, et al.
Eficacia de la terlipresina en la prevención de la disfunción circulatoria post-paracentesis en pacientes con cirrosis y ascitis. Estudio en fase II [resumen].
Gastroenterol Hepatol, 27 (2004), pp. 73
[35.]
A. Follo, J.M. Llovet, M. Navasa, R. Planas, X. Forns, A. Francitorra, et al.
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.
Hepatology, 20 (1994), pp. 1495-1501
[36.]
M. Navasa, A. Follo, X. Filella, W. Jiménez, A. Francitorra, R. Planas, et al.
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.
Hepatology, 27 (1998), pp. 1227-1232
[37.]
C. Terra, M. Guevara, T. Restuccia, A. Torre, R. Gilabert, C. Alessandria, et al.
Síndrome hepatorrenal inducido por infecciones bacterianas distintas de la peritonitis bacteriana espontánea en pacientes con cirrosis. Estudio prospectivo [resumen].
Gastroenterol Hepatol, 27 (2004), pp. 70
[38.]
P. Sort, M. Navasa, V. Arroyo, X. Aldeguer, R. Planas, L. Ruiz delÁrbol, et al.
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
N Engl J Med, 341 (1999), pp. 403-409
Copyright © 2005. Elsevier España S.L.. Todos los derechos reservados
